ANGELA YATES-GRIFFIN: Open Payments
NPI 1316350713 · SEMINOLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 8 payments from 5 companies in 2025. Trend: 2023 $495 · 2024 $79 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Amgen Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: OTEZLA, UBRELVY, GEMTESA, MOUNJARO, VRAYLAR, QULIPTA, REXULTI.
Industry payments across OK — which companies pay providers there.
